- Report
- October 2018
- 293 Pages
Global
From €21269EUR$22,000USD£18,269GBP
Lidoderm is a topical analgesic patch used to treat pain associated with post-herpetic neuralgia (PHN). It is a transdermal patch containing the active ingredient lidocaine, which is a local anesthetic. The patch is applied directly to the affected area and works by blocking nerve signals that cause pain. It is typically used for short-term relief of pain, and is not intended for long-term use.
Lidoderm is part of the analgesic market, which includes a variety of products used to treat pain. These products range from over-the-counter medications such as ibuprofen and acetaminophen, to prescription medications such as opioids and non-steroidal anti-inflammatory drugs (NSAIDs).
The analgesic market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more